Yuki Nakagawa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

A Case of Incidentally Resected Neuroendocrine Tumor in a Meckel's Diverticulum

A Case of Incidentally Resected Neuroendocrine Tumor in a Meckel's Diverticulum

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 07, 2026

A Case of Mesenteric Desmoid Tumor Arising during Follow-Up of the Clinical Course of Ulcerative Colitis

A Case of Mesenteric Desmoid Tumor Arising during Follow-Up of the Clinical Course of Ulcerative Colitis

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 07, 2026

Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer.

Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer.

Journal: Anticancer research

Published: March 20, 2026

A Case of Descending Colon Cancer with Splenic Abscess and Portal Venous Gas

A Case of Descending Colon Cancer with Splenic Abscess and Portal Venous Gas

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Comparison of parametric and hybrid methods for estimating mean survival time in clinical study.

Comparison of parametric and hybrid methods for estimating mean survival time in clinical study.

Journal: Journal of biopharmaceutical statistics

Published: September 09, 2025

Renal Functional Outcomes in Robot-Assisted Partial Nephrectomy with Minimum Layer Resection Using Virtual Three-Dimensional Image Assistance.

Renal Functional Outcomes in Robot-Assisted Partial Nephrectomy with Minimum Layer Resection Using Virtual Three-Dimensional Image Assistance.

Journal: Journal of clinical medicine

Published: September 05, 2025

Sarcoid neuropathy exhibiting intraneural nodule with central hypointensity on short-tau inversion recovery imaging: a heron-like appearance.

Sarcoid neuropathy exhibiting intraneural nodule with central hypointensity on short-tau inversion recovery imaging: a heron-like appearance.

Journal: Neuromuscular disorders : NMD

Published: May 16, 2025

Risk of malignant neoplasms of tacrolimus in kidney transplant patients: a retrospective cohort study conducted using the Japanese National Database of Health Insurance Claims.

Risk of malignant neoplasms of tacrolimus in kidney transplant patients: a retrospective cohort study conducted using the Japanese National Database of Health Insurance Claims.

Journal: BMC nephrology

Published: November 17, 2024

Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150.

Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150.

Journal: Liver cancer

Published: August 28, 2024

Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers.

Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers.

Journal: Journal for immunotherapy of cancer

Published: June 24, 2024

Erythema Nodosum Secondary to CD5-Positive Diffuse Large B-Cell Lymphoma as a Paraneoplastic Symptom: A Case Report.

Erythema Nodosum Secondary to CD5-Positive Diffuse Large B-Cell Lymphoma as a Paraneoplastic Symptom: A Case Report.

Journal: Case reports in oncology

Published: June 11, 2024

Reply to the Letter Regarding "Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study".

Reply to the Letter Regarding "Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study".

Journal: Liver cancer

Published: April 18, 2024

Showing 1-12 of 85

Last Updated: 09/26/2026